Improving Adherence to Topical Medication in Patients with Glaucoma

Area of Science:

• Ophthalmology
• Public Health
• Pharmacology

Background:

• Glaucoma is a leading cause of irreversible blindness globally, characterized by heterogeneous conditions.
• Lowering intraocular pressure (IOP) via topical medication is the primary evidence-based treatment to slow glaucoma progression.
• Adherence to anti-glaucoma therapy is notably low, even compared to other chronic disease management regimens.

Purpose of the Study:

• To review existing evidence on strategies for improving adherence and persistence with anti-glaucoma medications.
• To identify effective interventions for enhancing patient compliance in glaucoma management.

Main Methods:

• A comprehensive PubMed search was conducted to gather relevant studies.
• Evidence regarding various adherence improvement approaches was systematically reviewed.

Main Results:

• Technological solutions like automated reminders show limited short-term efficacy.
• Instillation aids have not demonstrated significant improvements in adherence.
• A multi-faceted strategy, combining patient education with other interventions, is more effective than education alone.
• Preservative-free eye drops offer comparable IOP control with improved tolerability and short-term adherence.

Conclusions:

• Improving adherence to glaucoma treatment requires a comprehensive, multi-faceted approach.
• Technological aids and improved medication tolerability are key components for enhancing patient persistence.
• Further research is essential, especially considering the rising global prevalence of glaucoma.